29 injections will be collected! It's sunny, Hengrui... 42 injections have been evaluated.

On September 29th, sichuan and eight other provinces and regions planned to purchase 17 drugs involving 14 injections.
, the news that the national harvest will increase the proportion of injections in the industry spread, a number of heavy injections have entered the provincial market catalog.
national mining and provincial and municipal collection of "double-punch" attack, more than 630 billion injection market accelerated shuffle.
this year, the progress of consistent evaluation of injectable generic drugs has accelerated significantly.
42 injections (77 regulations) have been adopted by enterprises/treated as if they were consistent evaluation.
In a new batch of collection did not start the empty window period and provincial and municipal collection did not include the trend of over-evaluation varieties, over-evaluation varieties ushered in a short-lived market golden period, unestamented, high sales of injection market will be subverted.
16 injections will be collected! Impact 12 more than 1 billion varieties september 24, Chongqing Municipal Health Insurance Bureau held a Chongqing drug belt procurement enterprise symposium, introduced the commonly used drug belt procurement documents in Chongqing, and listen to the participants on the procurement documents.
according to the online catalogue, Chongqing City intends to carry out with-volume procurement of 20 varieties.
sales of 20 proposed purchase varieties in Chongqing. Source: Milnet China's public medical institutions terminal competition pattern Minet data show that 20 varieties (23 product rules) in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sales of more than 1 billion yuan in 2019.
from the treatment field of 20 varieties, there are 7 varieties involved in anti-infectant drugs in the whole body, all of which are clinically commonly used large varieties.
the much-watched proton pump inhibitors (PPI), the sales of sodium glyphosate injection powder needles (40mg) were close to 4 billion yuan, and the sales of reberazole sodium intestinal solvents (10mg, 20mg) exceeded 2 billion yuan.
from the dosage form, 16 of the 20 varieties are injections (powder needles, water needles), intestinal solvents have 2 varieties, oral tablets, inhalers have 1 variety each.
it is worth noting that 20 varieties corresponding to the volume of procurement dosage forms have not been products through the consistent evaluation, Osali platinum evaluation products have Qilu Pharmaceutical's Oshali platinum injection, but this collection of injections for powder injection with Osali platinum.
8 provinces and regions joint belt volume procurement, 14 injections were included in September 29, the industry outflow of "Sichuan and other 8 provinces and regions to carry out inter-provincial alliance drug centralized belt procurement announcement", Sichuan, Shanxi, Inner Mongolia, Liaoning, Jilin, Heilongjiang, Hainan, Tibet and other 8 provinces (regions), will be 17 kinds of drugs centralized belt procurement.
injections are the main dosage forms purchased in this volume, 14 of the 17 drugs in the catalogue are injections and only 3 are oral regular release agents.
, compared with Sichuan and other 8 provinces and cities, Chongqing City collection of drugs catalog, seven-leaf saponin injection is the only combined varieties.
meters of intranet data show that 17 kinds of procurement of drugs in 2019 in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal sales of more than 1 billion yuan.
8 provinces (regions) 17 with volume procurement varieties sales of national "name-name" injections, a batch of injections by the local collection recently, a related talk about the national drug collection in the industry spread.
It is learned that the national collection will be carried out normally, as long as the number of varieties that meet the conditions for collection or its amount reaches a certain level, that is, trigger the start of national collection, is expected to carry out two batches per year;
September 17, Shandong Provincial Health Insurance Bureau issued the "Shandong Province drug centralized band procurement document (draft for comments)," will be 40 varieties of centralized band procurement.
28 of the 40 varieties of injections accounted for 70%, of which 23 injections in China's public medical institutions in 2019 terminal sales of more than 1 billion yuan.
20 varieties planned to be purchased with a volume, the proportion of injections is as high as 80%.
September 28, the Sichuan Provincial People's Government issued the Implementation Plan for the Centralized Procurement of Drugs by Pharmaceutical Institutions in Sichuan Province (Draft for Comments). The
program says that the province's public medical and health institutions (including military medical institutions involved in centralized procurement in our province), medical insurance fixed-point social-run medical institutions, medical insurance fixed-point retail pharmacies into the province's centralized drug procurement management;
specific procurement varieties are selected according to the corresponding rules.
can be seen that the centralized procurement of drugs, whether in the country or in various regions, are in the process of vigorously advancing, injections will be the first to be the first.
42 injections have been evaluated! It's sunny, Hengrui... In 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal drug injection sales exceeded 630 billion yuan, accounting for nearly 60% of the chemical drug market.
Such a huge drug market, in the context of the tightening of health insurance fee control policy, chemical injections are bound to be the focus of the Health Insurance Bureau, over-evaluation of injections will speed up the integration into the national harvest, not assessed injection varieties have also appeared in the provincial market collection directory.
year, the number and speed of evaluation of injection generics consistency has been greatly improved.
meters of intranet data show that as of September 30, 2020, 42 injections (77 standards) have been adopted by enterprises or as if through the consistency evaluation.
In addition, Shanghai Yifeng Pharmaceutical's magnesium sulfate injection, Hainan Puli Pharmaceutical's injection of Pyra lutein, Jiangsu Yingke Bio's propofol medium/long chain fat milk injection, Jiangsu Wangao Pharmaceuticals' left ethyl laxitan injection, Jiangsu Duri Pharmaceutical's application for the listing of methyl sulfonate has entered the administrative approval stage, is expected to be approved in recent days and considered as the same.
Injections by/as well as through consistency evaluation Source: Mienet MED2.0 China Drug Review Database From the evaluation of varieties, injection with yew alcohol (albumin binding), ibuprofen injection, left ethyl iracetam injection with a thick solution, injection with Paresib sodium and other 4 injections over-evaluation enterprises up to 3 And above; hydrochloric acid right metotomic injection, injection with azatron, hydrochloride bromosine injection, dosso-tea-alkali injection, hydrochloric acid moxisacin sodium chloride injection, iodiopaol injection, Loxyfluoxacin sodium chloride injection and other 7 injection evaluation enterprises have 2, the rest of the injections are exclusive evaluation.
From the enterprise evaluation situation, China Biopharmaceuticals (Zhengda Tianqing, Zhengda Fenghai) with 6 injection varieties leading, Hengrui Pharmaceuticals has 5 injection varieties over-evaluation, Huiyu Pharmaceuticals, Qilu Pharmaceuticals, Colum Pharmaceuticals, Steyri and other 4 enterprises have 3 injection varieties over-evaluation.
In the three batches carried out in the country, a total of 7 varieties of injections were included, namely, fluobilofen ester injection, injection of pyrithione dnaturate, hydrochloric acid right metomidin injection, injection of yew alcohol (albumin binding type), injection of aza cytosine, left ethyl elasitan injection with a thick solution, hydrochloric acid moxisa star sodium chloride injection.
In the new batch of collection did not start the empty window period and provincial and municipal collection did not include the trend of over-evaluation varieties, over-evaluation varieties ushered in a short-lived market golden period, especially the exclusive over-evaluation of varieties to open up the market a great opportunity.
not yet evaluated varieties enterprises not only to meet the challenges of local harvesting, but also to speed up the progress of generic drug consistency evaluation.
.